Related Experiment Video

Updated: Jun 26, 2026

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells

Nora A Barrett1, Akiko Maekawa, Opu M Rahman

  • 1Department of Medicine, Harvard Medical School, and Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|January 7, 2009
PubMed

Insights

House dust mites and mold trigger allergic inflammation by stimulating cysteinyl leukotrienes (cys-LTs) via the Dectin-2 receptor on immune cells. This identifies a new pathway in allergic responses.

Area of Science:

  • Immunology
  • Allergology
  • Molecular Biology

Background:

  • House dust mites are a major global allergen source.
  • The mechanisms driving potent allergic inflammation are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which house dust mite and mold allergens activate immune cells.
  • To identify the specific receptor involved in initiating allergic inflammation.

Main Methods:

  • Extracts from Dermatophagoides farinae (Df), Dermatophagoides pteronyssinus, and Aspergillus fumigatus were used to stimulate mouse bone marrow-derived dendritic cells (BMDCs).
  • Affinity chromatography, Syk inhibitors, and FcRgamma-/- mice were used to identify the involved signaling pathways.
  • Dectin-2 and DC immunoactivating receptor were tested for their role in mediating cysteinyl leukotriene (cys-LT) production.
  • Lentiviral knockdown of Dectin-2 in BMDCs was performed to confirm its role.

Main Results:

  • Allergen extracts induced robust production of cysteinyl leukotrienes (cys-LTs) from BMDCs.
  • Dectin-2 was identified as the key receptor mediating cys-LT production in response to these allergens.
  • Knockdown of Dectin-2 significantly reduced allergen-induced cys-LT generation.
  • Lung CD11c+ cells, but not other myeloid cells, produced cys-LTs upon allergen exposure.

Conclusions:

  • Dectin-2 is the primary receptor for initiating cys-LT production by indoor allergens like house dust mites and mold.
  • The Dectin-2/FcRgamma/Syk/cys-LT axis represents a novel pathway in innate immune cell activation driving allergic inflammation.
  • This discovery offers potential new targets for managing allergic diseases.

More Related Videos

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation07:52

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Published on: July 23, 2012

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...